tldrdailynews.com logo

OpenAI rolls out life sciences AI to speed drug discovery

1 min read
Source: Axios
OpenAI rolls out life sciences AI to speed drug discovery
Photo: Axios
TL;DR

OpenAI launches GPT-Rosalind, a life sciences-focused AI model designed to accelerate research in genomics and biochemistry by synthesizing evidence and generating hypotheses, while keeping humans in the loop; it features enterprise-grade security and is being rolled out in a research preview to trusted customers (e.g., Amgen, Moderna, Allen Institute, Thermo Fisher) to speed health outcomes and drug discovery without replacing scientists, amid concerns about misuse.

Topics:businesstechnology#ai-safety#artificial-intelligence#biomedicine#drug-discovery#life-sciences#technology
Share this article
  1. OpenAI launches new AI model for life sciences research  Axios
  2. Introducing GPT-Rosalind for life sciences research  OpenAI
  3. OpenAI Takes on Google With New AI Model Aimed at Drug Discovery  Bloomberg.com
  4. OpenAI starts offering a biology-tuned LLM  Ars Technica
  5. OpenAI Targets Pharma Giants With Purpose-Built AI Model  PYMNTS.com

Want the full story? Read the original reporting

Read on Axios